Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Related Citations for PubMed (Select 10760291)

1.

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.

Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE.

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4233-8.

2.

Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.

Valiente M, Andrés-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R.

J Biol Chem. 2005 Aug 12;280(32):28936-43. Epub 2005 Jun 10.

3.

Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.

Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA.

J Biol Chem. 2000 Jul 14;275(28):21477-85.

4.

Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.

Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR.

J Biol Chem. 2001 Dec 28;276(52):48627-30. Epub 2001 Nov 13.

5.

Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.

Leslie NR, Bennett D, Gray A, Pass I, Hoang-Xuan K, Downes CP.

Biochem J. 2001 Jul 15;357(Pt 2):427-35.

6.

Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness.

Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E.

FASEB J. 2005 Jan;19(1):115-7. Epub 2004 Nov 1.

7.

The membrane-associated guanylate kinase protein MAGI-1 binds megalin and is present in glomerular podocytes.

Patrie KM, Drescher AJ, Goyal M, Wiggins RC, Margolis B.

J Am Soc Nephrol. 2001 Apr;12(4):667-77.

8.

Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383.

Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC, Chan AM.

Cancer Res. 2001 Jul 1;61(13):4985-9.

9.

Carom: a novel membrane-associated guanylate kinase-interacting protein with two SH3 domains.

Ohno H, Hirabayashi S, Kansaku A, Yao I, Tajima M, Nishimura W, Ohnishi H, Mashima H, Fujita T, Omata M, Hata Y.

Oncogene. 2003 Nov 20;22(52):8422-31.

PMID:
14627983
10.

A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains.

Sotelo NS, Valiente M, Gil A, Pulido R.

J Cell Biochem. 2012 Aug;113(8):2661-70. doi: 10.1002/jcb.24141.

PMID:
22434720
12.

Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts.

Wegmann F, Ebnet K, Du Pasquier L, Vestweber D, Butz S.

Exp Cell Res. 2004 Oct 15;300(1):121-33.

PMID:
15383320
13.

Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.

St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E.

Int J Oncol. 2004 May;24(5):1311-24.

PMID:
15067356
14.

Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2110-5.

15.

MAGI-1: a widely expressed, alternatively spliced tight junction protein.

Laura RP, Ross S, Koeppen H, Lasky LA.

Exp Cell Res. 2002 May 1;275(2):155-70.

PMID:
11969287
16.
17.

Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.

Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL.

Cancer Res. 2000 Jan 1;60(1):35-7.

18.

PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.

Bruni P, Boccia A, Baldassarre G, Trapasso F, Santoro M, Chiappetta G, Fusco A, Viglietto G.

Oncogene. 2000 Jun 29;19(28):3146-55.

19.

Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions.

Torres J, Rodriguez J, Myers MP, Valiente M, Graves JD, Tonks NK, Pulido R.

J Biol Chem. 2003 Aug 15;278(33):30652-60. Epub 2003 Jun 3.

20.

Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.

Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB.

J Biol Chem. 2003 Oct 10;278(41):40057-66. Epub 2003 Jul 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk